You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →
Amsterdam’s Phosphoenix raises €1.3 million to advance its neuroprosthetic system for people with profound blindness, with support from existing investors and ROM InWest.
PRIVATESep 18, 2026•about 3 hours ago
Amount Raised
€1.3 Million
Round Type
Seed
AmsterdamBiotechnologyHealth Care
Investors
Rom In WestInnovatiefonds Noord HollandFirst FundTtt Medtech Fund
Description
Phosphoenix, a MedTech startup, has raised €1.3 million to advance its neuroprosthetic system for individuals with profound blindness. This funding will support the company's first-in-human clinical study and the development of its neurostimulation technology. The financing was supported by existing investors including TTT Medtech Fund and FIRST Fund, along with new investor ROM InWest. This marks a significant step towards clinical application and future Series A financing.
Company Information
Company
Phosphoenix
Location
Amsterdam, North Holland, Netherlands
About
Phosphoenix is an Amsterdam-based MedTech startup focused on developing a neuroprosthetic system intended to restore functional vision for individuals with profound blindness. Founded in 2019, the company aims to stimulate nerve cells in the visual perception areas of the brain, addressing an unmet need in effective blindness treatments. Their technology involves a proprietary high-density neural interface designed for implantation in the lateral geniculate nucleus of the brain.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Phosphoenix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.